Nikki Romero, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 239 E Grand River Rd Apt 2, Laingsburg, MI 48848 Phone: 615-926-1679 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company has completed business negotiations with one of the U.S. Government's top national security research institutions regarding the acquisition of rights to the Integrated Optical Biosensor System (IBOS) technology developed by the laboratory personnel. Biomagnetics Diagnostics plans to utilize this technology to enter the significantly underserved market for handheld biosensors capable of detecting a broad range of disease-causing viruses, bacteria and fungi.
CANCER RESEARCH UK Cancer Research UK scientists have discovered why a sub group of oestrogen-receptor-negative breast cancer patients could benefit from prostate cancer treatments which target the cell's androgen receptor - a key driver of prostate cancer, according to research published in The EMBO Journal today.
The Christian Science Monitor: Even after the GOP win in Massachusetts that cost Democrats their "filibuster-proof margin in the Senate," congressional Republican leaders say Democrats don't appear to want to work with them on a health care plan that could clear Congress, according to The Monitor Breakfast.
One of Europe's largest cancer centres, The Christie NHS Foundation Trust, has become the first in the country to provide a treatment called Phesgo for breast cancer patients in their own homes. Phesgo is a combination of Herceptin
Extreme values of serum uric acid levels in the blood can markedly reduce a patient's chance of surviving and reduce their lifespans by up to 11 years, according to a new study by researchers at University of Limerick's School of Medicine.
› Verified 6 days ago